DE3790883T1 - - Google Patents

Info

Publication number
DE3790883T1
DE3790883T1 DE19873790883 DE3790883T DE3790883T1 DE 3790883 T1 DE3790883 T1 DE 3790883T1 DE 19873790883 DE19873790883 DE 19873790883 DE 3790883 T DE3790883 T DE 3790883T DE 3790883 T1 DE3790883 T1 DE 3790883T1
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19873790883
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DE3790883T1 publication Critical patent/DE3790883T1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE19873790883 1987-01-20 1987-12-23 Withdrawn DE3790883T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US547187A 1987-01-20 1987-01-20

Publications (1)

Publication Number Publication Date
DE3790883T1 true DE3790883T1 (de) 1988-12-08

Family

ID=21716038

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19873790883 Withdrawn DE3790883T1 (de) 1987-01-20 1987-12-23

Country Status (7)

Country Link
EP (1) EP0309491A1 (de)
JP (1) JPH01501864A (de)
DE (1) DE3790883T1 (de)
GB (1) GB2209338A (de)
NL (1) NL8720745A (de)
SE (1) SE8803309L (de)
WO (1) WO1988005438A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335770B1 (de) * 1988-04-01 1997-01-15 Merrell Pharmaceuticals Inc. Derivate von Fluorphosphonat-Nukleotiden
US5208221A (en) * 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
AU2641192A (en) * 1991-09-24 1993-04-27 Wellcome Foundation Limited, The Therapeutic nucleosides
US5532225A (en) * 1992-07-31 1996-07-02 Sri International Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods
AU690587B2 (en) * 1993-09-17 1998-04-30 Gilead Sciences, Inc. Method for dosing therapeutic compounds
US5798340A (en) 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5717095A (en) * 1995-12-29 1998-02-10 Gilead Sciences, Inc. Nucleotide analogs
US5877166A (en) * 1996-04-29 1999-03-02 Sri International Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
US5922695A (en) * 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
CN105596356A (zh) 2003-01-14 2016-05-25 吉里德科学公司 用于联合抗病毒治疗的组合物和方法
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1288098C (en) * 1984-08-24 1991-08-27 Richard L. Tolman 4-(guanin-9-yl)butanals and their 3-oxa, 3-thia and 2-ene derivatives having antiviral and antitumor activity

Also Published As

Publication number Publication date
GB2209338A (en) 1989-05-10
WO1988005438A1 (en) 1988-07-28
NL8720745A (nl) 1988-12-01
EP0309491A1 (de) 1989-04-05
GB8821380D0 (en) 1988-11-02
SE8803309D0 (sv) 1988-09-19
SE8803309L (sv) 1988-09-19
JPH01501864A (ja) 1989-06-29

Similar Documents

Publication Publication Date Title
DE3871528D1 (de)
DE8701435U1 (de)
DE8704509U1 (de)
DE8701689U1 (de)
DE8704779U1 (de)
DE8701920U1 (de)
DE3873187D1 (de)
DE8704953U1 (de)
DE8703060U1 (de)
DE8702910U1 (de)
DE8703924U1 (de)
DE8705246U1 (de)
DE8702501U1 (de)
DE8703374U1 (de)
DE8701612U1 (de)
DE8700465U1 (de)
DE8704989U1 (de)
DE8704838U1 (de)
DE8701604U1 (de)
DE8702588U1 (de)
DE8703258U1 (de)
DE8702956U1 (de)
DE8705157U1 (de)
DE8701770U1 (de)
DE8700162U1 (de)

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee